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Aim: To establish what factors are important for patients to engage in a new interven-
tion for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and make
recommendations to general practitioners (GPs) on preparing a patient for referral to
such a service. Background: NICE guidelines recommend a prominent role for primary
care in the management of patients with CFS/ME, with prompt diagnosis and appro-
priate referral for evidence-based treatments. Methods: A qualitative study nested
within a multi-centre randomised controlled trial of two new nurse therapist delivered
interventions. Semi-structured interviews carried out with 19 patients who had received
pragmatic rehabilitation (PR) in the trial. Interviews were transcribed verbatim and an
iterative approach used to develop themes from the data set. Findings: Factors that
influence whether or not a patient engages with PR for CFS/ME are ensuring that the
patient feels accepted and believed, that they accept the diagnosis, and that the model
implicated by the treatment offered to the patient matches the model of illness held by
the patient. If patients hold a clearly incompatible model of their illness, it is unlikely that
they will engage with, and successfully complete, therapy. It is vital that the GP elicits
and explores such illness beliefs either before making a referral to maximise patient
engagement in therapy, or that an initial session with the therapist explores attitudes to
the treatment model offered and then works with the patient’s model.
Key words: chronic fatigue syndrome/myalgic encephalitis; engagement; pragmatic
rehabilitation; qualitative methods
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Introduction
Chronic fatigue syndrome/myalgic encephalo-
myelitis (CFS/ME) is a symptomatically defined
condition characterised by a minimum of six
months severe physical and mental fatigue of
new onset which cannot be explained by other
medical causes (Fukuda et al., 1994). Functional
impairment is substantial and a number of other
physical, cognitive, and neuropsychiatric symp-
toms may be present (CFS/ME WG, 2002). Pre-
valence estimates vary but the Joint Working
Group’s 2002 report to the UK’s Chief Medical
Officer (CFS/ME WG, 2002) suggests a popula-
tion prevalence of at least 0.2–0.4% in the United
Kingdom. The condition is associated with high
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levels of disability and healthcare use (McCrone
et al., 2003). The annual economic impact of CFS
in the United States is estimated to be $9.1 billion
in lost productivity, not including medical costs or
disability payments. The average family affected
by CFS/ME loses $20 000 a year in wages and
earnings (Fukuda et al., 1994). The prognosis of
CFS/ME is variable and it is suggested that only a
small minority of patients recover to previous
levels of health or functioning (CFS/ME WG,
2002).
A number of different approaches to the man-
agement of CFS/ME are used in clinical settings
including cognitive behaviour therapy (CBT), gra-
ded exercise therapy (GET), and counselling
(Sharpe et al., 1996; Whiting et al., 2001; Chambers
et al., 2006; Price et al., 2008). Guidelines for treat-
ment provided by the National Institute for Health
and Clinical Excellence (NICE) in the United
Kingdom (2007) suggest that CBT and GET,
delivered by specialist therapists, show the clearest
evidence of benefit from the available published
research.
NICE guidelines advocate a prominent role for
primary care and suggests that healthcare profes-
sionals should aim to establish a supportive and
collaborative relationship, working in partnership
with the adult or child with CFS/ME, family, and
carers to facilitate their effective management. The
guidelines emphasise the importance of a defini-
tive diagnosis and suggest that referral to a spe-
cialist should be made on the basis of the person’s
needs and symptoms: within six months of pre-
sentation to those with mild symptoms, within
three to four months to those with moderate
symptoms, and immediately to those with severe
symptoms.
In 2004, following on from the report to the
Chief Medical officer (CFS/ME WG, 2002) the
UK Department of Health established a number
of local clinical network coordinating centres to
support and develop the work of specialist ser-
vices and local multi-disciplinary teams engaged
in the treatment and management of CFS/ME
across the country. There are now 13 centres,
which provide a range of services including, in
some centres, CBT and GET, although there are
regional variations in the availability of these
treatments and referral practices of general prac-
titioners (GPs) to the services (CFS/ME Service
Investment Programme Report, 2004–2006).
Previous literature outlines the negative views
and scepticism that GPs express towards people
with CFS/ME (A˚sbring and Na¨rva¨nen, 2003;
Raine et al., 2004). In addition, sufferers have
been shown to be dissatisfied with the medical
care they receive (Ax et al., 1997) and an adver-
sarial nature to medical consultations has been
described (Cooper, 1997). Our previous work
suggests that GPs find making the diagnosis of
CFS/ME difficult (Chew-Graham et al., 2010) and
this at least partly relates to uncertainty over the
nature of the condition; it seems that GPs may
not have a useful explanatory model about CFS/
ME and that the model may vary between GPs
and may, indeed, shift in the course of a GP’s
career (Chew-Graham et al., 2008). If the GP
does not have a model he/she feels comfortable
with, then discussing the diagnosis of CFS/ME
with a patient may become problematic (Chew-
Graham et al., 2008). This may result in difficul-
ties in agreeing the nature of the illness with the
patient and negotiating appropriate referral for
further management (Chew-Graham et al., 2010).
There is considerable evidence that when peo-
ple experience a threat to their health such as
symptoms or chronic illness, they are motivated
to form an understanding or personal model of
that threat, to guide their attempts to neutralise
the threat, that is to get well (Leventhal et al.,
1984). In the case of CFS/ME, where there is no
medical explanation for fatigue and often no
treatment advice forthcoming, patients struggle
to make sense of their illness, and may develop
models of their illness in which fluctuating
symptoms are interpreted as evidence of bodily
damage or relapse (Deary et al., 2007). Cognitive
behavioural approaches to CFS/ME may help
patients consider whether their personal model of
their illness is helpful for them in their attempts
to become well.
Pragmatic rehabilitation (PR) is a therapist-
facilitated self-management intervention for CFS/
ME, which shares features in common with CBT
and GET, but which does not require a specialist
CBT or physiotherapist to deliver it. PR con-
ceptualises the symptoms experienced by people
with CFS/ME as a consequence of physiological
dysregulation, including cardiovascular and mus-
cular deconditioning and disruption of sleep–
wake cycles. PR differs from conventional CBT in
that the treatment starts with an explicit presentation
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of the PR explanatory model for CFS/ME, sup-
ported by a referenced manual. Treatment involves
a graded activity schedule carefully monitored to
be well within the patient’s abilities, with gradual
increments, regularisation of sleep, and the colla-
borative development of plans working towards
rehabilitation (Wearden and Chew-Graham, 2006).
There is evidence that PR is effective in secondary
care (Powell et al., 2001) and a recent trial (Wear-
den et al., 2006) suggests that PR is effective for
some patients in primary care, but the effect is not
sustained (Wearden et al., 2010). Moss-Morris and
Hamilton (2010) suggest that more work is needed
to determine for whom PR works best and the
factors that make it an acceptable treatment to
people with CFS/ME.
This qualitative study aimed to establish the
factors which are important for patients to engage
in this novel intervention for CFS/ME within a
trial (Wearden et al., 2006; 2010) and to extra-
polate the findings to make recommendations for
the referral process to such a service, were it to be
commissioned.
Methods
The sample was drawn from patients participating
in a randomised controlled trial of two nurse-led
interventions for CFS/ME in primary care: the
FINE trial (Wearden et al., 2006). Patients were
recruited from 44 primary care trusts in the North
West of England into the trial. Practices were
contacted and GPs invited to refer registered
patients with CFS/ME to the trial. Patients were
considered eligible if they were aged 18 or above,
fulfilled the Oxford inclusion criteria for CFS/
ME, scored 70% or less on the SF-36 physical
functioning scale (Ware and Sherbourne, 1992)
and scored four or more on the 11-item Chalder
fatigue scale (Chalder et al., 1993). Following
consent, eligible patients were randomised to one
of the three arms: PR, supportive listening (SL),
or treatment as usual. Full details of the inter-
ventions and trial recruitment procedures are
provided elsewhere (Wearden et al., 2006).
Sampling for this qualitative study was purposive.
A total of 42 patients were interviewed follow-
ing the completion of the 18-week intervention,
of which 19 had been in the PR arm of the trial.
Table 1 outlines details of the participants in the
study reported here. Sampling was purposive to
achieve mix of gender, age, postcode, and dura-
tion of illness (time since diagnosis), SF36 post-
treatment and CALPAS scores. Semi-structured
interviews were conducted between November
2005 and March 2008. Respondents were inter-
viewed by members of the research team in their
own homes. Interview guides provided a flexible
framework for questioning and explored a num-
ber of areas including patients’ views on the
treatment intervention. The interviewer used a
combination of open questions to elicit free
responses, and focused questions for probing and
prompting. Interviews lasted between about 30
and 90minutes. Interviews were digitally recorded
and transcribed verbatim.
Analysis proceeded in parallel with the inter-
views and was inductive. Coding was informed by
the accumulating data and continuing thematic
analysis (Malterud, 2001). Transcripts were read
and discussed by researchers from different pro-
fessional backgrounds: primary care and psy-
chology (Henwood and Pidgeon, 1992). Thematic
categories were identified in initial interviews
which were then tested or explored in subsequent
interviews where disconfirmatory evidence was
sought (Strauss and Corbin, 1998). Interpretation
and coding of the data were undertaken by all
the authors and the themes were agreed upon
through discussion. An overall set of master
themes was identified and a comprehensive cor-
pus of extracts supporting each theme produced.
The narrative account reported below focuses
on the factors that influence engagement in the
PR intervention from the perspective of patients.
This analysis aimed to identify the meaning of the
experiences being reported, particularly with
respect to the experiences within the patient-trial
nurse encounter. Data reporting other aspects of
this study are reported elsewhere (Chew-Graham
et al., 2008; Peters et al., in preparation). In
reporting the final analysis, data are presented
from transcripts of interviews of participants who
had been in the PR arm of the trial, to illustrate
the range and commonality of meaning of each
category of analysis. Although qualitative analysis
of this type is inevitably subjective, extracts allow
the reader to make their own assessments of the
interpretations made. The wide use of verbatim
extracts is intended to attest to the credibility of
the final account.
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Results
Three factors emerged as key in the analysis:
i) feeling accepted and believed by the therapist,
ii) own acceptance of the diagnosis, and iii) accep-
ting model of illness presented by the therapist.
Feeling accepted by the therapist
For many patients, their belief that they were fully
understood by the nurse therapist both personally
and in terms of their illness condition was empha-
sised. Talking to someone who listened and under-
stood was described by a number of patients as the
most positive part of the treatment intervention:
It was just an understanding from her that I
didn’t, haven’t had from anybody else.
(P30)
For those patients who described feeling understood
by the therapist, this was described as a novel
experience and in stark contrast to the disbelief and
scepticism encountered elsewhere in their encounters
with health professionals. Patients often attributed
this to the invisibility of the condition:
somebody sitting there saying to you, I know
what you are going through and I have got other
people who are going through the same thing,
and if you look up this booklet, that’s exactly you
know, you can describe yourself in a booklet and
before, I had never really been able to pinpoint
myself, or box myself, to anywhere particular.
(P28)
Being believed and feeling understood by the
therapist emerged as key factors in the formation
of a positive relationship. Trial nurses were
described in glowing terms both personally and in
terms of their professional expertise:
She was a cracker, I couldn’t fault her.
(P32)
Well she was very encouraging all along and I
was very impressed with her whole attitude.
(P10)
Table 1 Participant details
ID Sex Age Marital status Townsenda
deprivation score
Months since
diagnosis
Sf-36 change
scores (baseline,
20 week)b
Calpas score
post treatmentc
1 Female 45 Cohabiting 7 9 months 210 (10, 0) 100
3 Female 25 Single 7 1.5 years 0 (25, 25) 50
5 Male 20 Single 3 3.5 years 15 (60, 75) 80
6 Female 37 Single 7 1 year 3 months 65 (20, 85) 100
10 Male 38 Single 1 16 years Missing (15,
missing)
50
12 Male 47 Married 7 1 year 5 (25, 30) Missing
20 Female 41 Married 23 16 years 10 (20, 30) Missing
22 Female 30 Single 21 8.5 years 35 (35, 70) 80
23 Female 58 Divorced 24 6 years 235 (35, 0) 80
26 Female 43 Single 1 2 years 10 (45, 55) 70
28 Female 23 Married 0 10 months 210 (55, 45) 70
29 Female 29 Cohabiting 5 1 year Missing (35,
missing)
90
30 Female 34 Single 7 3 years 10 (50, 60) 100
32 Male 60 Married 23 8 years 40 (25, 65) 100
35 Male 58 Married 1 18 years 5 (0, 5) 50
37 Female 53 Married 25 1 year 0 (30, 30) 100
38 Female 27 Cohabiting 1 4 years 60 (35, 95) Missing
40 Male 48 Married 0 9 years 25 (45, 70) 60
41 Female 61 Married 2 10 years 20 (10, 30) 50
a Townsend P, Philmore P, Beattie A. Health Deprivation: Inequality and the North. London: Croom Helm; 1988.
bScores range from 0 (lowest functioning) to 100 (highest functioning). Change scores 20 week – baseline.
c Scores for response to question ‘does the type of treatment you are receiving match your ideas about what helps
people with your illness?’ Scores range from 0 (not at all) to 100 (very much).
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However, being heard and understood seemed to
be of greater value than the professional medical
knowledge attributed to the therapist:
At the actual end of it (treatment), I felt like I
had lost somebody reallyy I mean you can
talk to some people, can’t you and obviously
I could talk to her because she understood.
A lot of people don’t understand. She would
listen to me and explain things and we were
on the correct level.
(P37)
The nurse therapist’s understanding of the patient
was evidenced for some by her perceived ability
to manage their condition flexibly within the
treatment protocol and to bring a fresh outside
perspective to problems which had appeared
insurmountable before.
I think the understanding and listening by
[Nurse C]. She understood what my pro-
blems were, and she listened to them. Told
me how to get round the different ones, how
to sort of beat the little buggers you know,
beat the little nasties, that was ruining my life.
(P32)
The extent to which the patient perceived
the nurse therapist, believed in their problems,
and understood them in a wider context was an
important factor in determining whether the
patients continued to engage with the therapy and
found the intervention offered acceptable.
Own acceptance of diagnosis
Some patients described the treatment inter-
vention offered as having been especially helpful
in terms of their accepting the diagnosis. Having
some explanation for and a greater understanding
of their symptoms were described as funda-
mentals in accepting the condition:
I hadn’t really accepted my illness when she
first came to visit me.
(P28)
I thought maybe she could give me some
information, you know, in order I suppose
really for me to actually believe that it was
ME. For me myself to believe it was ME, not
other people, because remember, I started
myself not believing it was ME, because
I was as ignorant as other people about it,
because I knew nothing you know.
(P6)
Thus, engaging with the therapy was dependent
upon the patient accepting what their symptoms
represented and the diagnostic that was applied.
Some patients described their interactions with the
nurse therapist as validating the illness, and the
diagnosis, convincing them as to the reality and
seriousness of their condition. Patients described
how their struggle to find an acceptable and satis-
factory model for the symptoms they experienced
was frightening. These patients thought that if they
could not explain their symptoms to themselves
in terms of physiological or physical processes,
the symptoms must have a ‘psychological’ origin.
Therfore, patients were buying into the physical
versus mental illness divide, and not liking the
conclusion that they might have a mental problem:
If I had a broken leg they could physically
see it, but many with chronic fatigue, there’s
nothing really visible.
(P3)
The increased knowledge about their symptoms
through the information provided (by the thera-
pist and in the manual) within the intervention
was described as reassuring:
At the beginning it was embarrassing,
because I didn’t know that was part of the
symptoms, I actually thought at one point I
was like cracking up.
(P1)
You don’t feel so alone in the fact that you
know, that your symptoms are there, and that
other people have these symptoms. Like I say
what I got off [Nurse A] was because she had
met with people and seen people who felt as I
did. And when she mentioned things and I
thought oh yes, that’s right, and I am, so I am
not going round the twist.
(P25)
Accepting their condition and diagnosis was
described as being necessary to allow progress
with treatment:
It’s the acceptance of what is wrong with me, if
you don’t accept it you can’t progress with it.
(P30)
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Accepting their diagnosis was also key for some
patients in terms of absolving them from guilt
they felt about their reduced ability to perform
activities and functioned as a means of enabling
patients to feel they had permission to do less,
leading to better control and management of their
symptoms.
I think I sort of denied there was anything
wrong with me, so I kept pushing on when I
knew that after I had done so much I would
crash, and it was seeing Nurse B that gave me
an understanding that I have to take a step
back and slow downy I have learnt to not
punish myself.
(P30)
Thus, acceptance of the label of CFS, either
before referral into the trial, or through discus-
sion of the therapy offered (by the nurse therapist
and the trial treatment manual), enabled the
patient to believe that the intervention might be
appropriate for them.
Acceptance of the model
The third factor that emerged as key in
engagement in the intervention was acceptance of
the model of the condition (CFS/ME) implied by
the treatment offered. Whether or not patients
perceived the nurse therapist as having a model
of the illness, which matched with their own
was vitally important. If the model presented
either provided no challenge to, or matched, the
patient’s existing illness model, then the treat-
ment intervention helped them formulate their
existing model in clearer terms:
A lot of this seemed sort of common sense
really like not sleeping in the daytime and stuff
but I don’t know, having someone discuss it
with me did make me more aware of it I think.
(P5)
Other patients described the treatment interven-
tion as providing a model for their condition
where there had been none previously. There
were frequent descriptions of how the treatment
intervention had resulted in patients’ better
understanding of the condition.
She explained all about CFS and the phy-
siology of it really, which was the first time
really that I understood why my energy was
so low, so that made a lot of sense.
(P38)
Where patients adopted the model presented
in the intervention, their reasoning for doing so
was based on the extent to which the model
presented was resonant with their own experience
of the illness and the extent to which the patient
perceived the model as making sense:
It hit me, because everything that went in
there, it was amazing, it was like, This is Your
LifeyEverything she said, in those para-
graphs, [in the patient manual] was regarding
my illness.
(P32)
When patients rejected the rationale for the
treatment offered, there were a number of rea-
sons given for this. Some patients held models of
the illness before treatment, which were contra-
dictory to that being presented by the nurse
therapist and remained unconvinced by the PR
model and the rationale for the treatment inter-
vention that it provides.
What I have got is not just a reconditioning
problem, I have got something where there is
damage and a complete lack of strength actu-
ally getting into the muscles and you can’t work
with what you haven’t got in terms of energy.
(P10)
I think my main reason is the fundamental
theory behind it [the treatment model
offered] just disregards it as illness.
(P3)
Some patients regarded the treatment inter-
vention as unsuitable for them because they per-
ceived their condition as being individual and
unique and, importantly, not amenable to treat-
ment. These patients described themselves as
experts in their own condition, and did not feel
that there was anything new they could usefully
learn about the condition.
But the other thing that upsets me about that
is that when the nurse came round and
explained the theory to me, it was sold to me
as fact, this is what is happening, there was
no element of this is actually quite a con-
tentious issue, I have done some research
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since and found evidence supporting both
camps and there was no part of that session
that said there are some people that don’t
believe this.
(P3)
Well I am like 17 years on so I have already
learnt I have to get on with it and live with it
really.
(P20)
Several patients held a model of the illness, which
implied that activity was potentially damaging, so
patients were fearful of relapse.
Well the sections here [in the manual], I have
marked them, like the section here that I didn’t
really agree with and I tried to tell her that I
didn’t agree, erm, like it says there is no hid-
den disease, I think there could be something
that they haven’t found you know. But activ-
ity/exercise cannot harm you, I think it can
harm you, if you are not good and you really,
really push yourself you can relapse, defi-
nitely. And I did try to tell her that, but I think
she was, rigid to the book and she thought that
was exact, I didn’t.
(P20)
In addition, patients who could not work the
management plan into their everyday life felt that
it was not a workable model:
Well it sounded logical. But applying it, I
think you needed not to have anything else
going on in your life, particularly out of the
ordinary, to be able to apply it properly and
really stick to it.
(P23)
It is unworkable in my opinion. From,
I mean I went into this feeling very positive,
feeling that I understood the theory, and
feeling that it made sense and its something
that I wanted to work for me and it was good
for me because it made me think right I can
take this into my own hands, I can make
myself better, but I don’t believe the funda-
mentals are right and you know, one of the
most documented things about this illness is
the delayed effect of activity and you know
that is quite a basic principle and so is the
principle of resting for 10minutes and then
you know you are within your limits and they
don’t go together at all.
(P3)
Thus, we suggest that a patient needs to feel that
they are believed and understood by the therapist
before engaging in the treatment offered. Engage-
ment can help the patient accept their own illness
and formulate an adequate explanation for the
symptoms experienced. If the patient’s model of
illness, either pre-existing or so formulated, is in
agreement with that of the therapist, the patient
feels further reassured that the therapist has a real
and genuine understanding of them and their con-
dition and thus continues to engage in the treat-
ment. Similarly, where models of treatment match,
the patient will engage with the intervention. If,
however, there is no matching of the patient’s
model of the cause of their symptoms of the model
of treatment offered, engagement and working with
the intervention offered is unlikely.
Discussion
Summary of results
This paper draws together data from interviews
with CFS/ME patients following their participa-
tion in a primary care trial nurse therapist deliv-
ered interventions for CFS/ME and identifies
the factors described by the patients as key in
influencing their level of engagement with one of
these interventions, PR. This intervention was
effective in the short-term, but the effect was
not sustained (Wearden et al., 2010). The factors
that seem to be important in engagement with
the therapy are ensuring that the patient feels
accepted and believed, that the patient accepts
the diagnosis, and that the model of treatment
offered to the patient matches the model held by
the patient. If the patient holds a clearly incom-
patible model it is unlikely that the patient will
engage with, and successfully complete, therapy.
A number of respondents rejected the inflexibility
of the presentation of the model, and this may be
due to the intervention being presented within a
randomised controlled trial, and may be less of an
issue in development of a service based on this
model of intervention, where more flexibility
could be offered.
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Strengths and limitations of the study
Data are presented from interviews with
patients who had received PR, a novel interven-
tion as part of a randomised controlled trial, and
thus the views are not necessarily generalisable to
all patients with CFS/ME. In addition, all patients
interviewed could have been said to have engaged
to a certain extent as they had completed the
intervention. Patients who had not entered or
engaged in the study were not interviewed. Patients
were recruited to the trial, however, from primary
care across a wide geographical area (Wearden
et al., 2006), and drawn from suburban, rural, and
inner city areas (see Table 1). In addition, sampling
was purposive to achieve mix of gender, age,
postcode, and duration of illness (time since diag-
nosis), SF36 post-treatment and CALPAS scores.
This purposive sampling enabled us to access a
range of views, particularly from participants who
had not improved (according to SF36) or were less
engaged (according to CALPAS). Using authors
from different professional and academic back-
grounds is a recognised technique for increasing
the trustworthiness of the analysis (Henwood and
Pidgeon, 1992).
Comparison with previous literature
Our findings suggest that for treatment inter-
ventions to be successful in engaging people with
CFS/ME, a number of points must be addressed.
It is vital that the patient is believed. A recent
systematic review of the expressed needs of peo-
ple with CFS/ME suggests that patients need to
first make sense of their symptoms and gain a
diagnosis, and desire recognition of their needs,
and respect and empathy from their service pro-
viders (Drachler et al., 2009). Our study confirms
this. The scepticism displayed by some GPs about
CFS/ME (A˚sbring and Na¨rva¨nen, 2003; Raine
et al., 2004) may be because they do not have a
satisfactory model of the condition which con-
vinces them of its reality as an illness and pro-
vides a potential rationale for management.
Patients may be aware of the controversial nature
of CFS/ME, and therefore particularly sensitive
to being disbelieved, so may put their energies into
convincing their doctors that their symptoms are
real (Horton-Salway, 2001). If patients feel that
their doctors do not really believe that they are ill,
especially in the context of past lack of medical
support or understanding, the patient–doctor rela-
tionship is likely to be undermined, and the patient
may be left with a feeling of having nowhere to go
(Chew-Graham et al., 2008).
An important aspect of the process of engaging
patients and forming a therapeutic alliance with
them is the development of an agreed model of
the patients’ problems, which provides the ratio-
nale for shared, collaborative goals for treatment.
We know from other conditions that when patients
and their doctors share an explanatory model,
patients are more satisfied with their treatment
(Callan and Littlewood, 1998). Furthermore, there
is some evidence that when treatment is in accor-
dance with patients beliefs about depression, they
are more likely to engage in it (Elkin et al., 1999).
Previous work with the pragmatic rehabilition
model has shown that it can be very effective in
helping patients to get better (Powell et al., 2001),
but this study suggests that if the model is not
believed by patients, it is less effective (Wearden
et al., 2010). Our data suggest that for those
patients who were struggling to develop a coherent
model of their own, or who had a personal model
which was unacceptable or unsatisfactory to them,
the simple provision of the PR model could be
immensely helpful. But for those patients who had
a firmly held pre-existing model of CFS/ME, the
mere exposure to an alternative formulation was
unlikely to result in the acceptance of the new
model in the absence of therapeutic work to con-
vince them of its utility or ‘socialise’ them to that
model (Roos and Wearden, 2009). In accordance
with Leventhal’s model (Leventhal et al., 1984),
one factor that is likely to influence the accept-
ability of an externally provided model is the
extent to which it resonates with patients’ own
personal symptom experiences.
In our analysis, we distinguished between the
themes of ‘feeling believed’ and ‘accepting the diag-
nostic label’. ‘Feeling believed’ refers to the patient’s
sense of being really understood and accepted by the
therapist, not just in terms of the symptoms experi-
ence but also in more general terms. The invisibility
of the condition allied with its chronicity may mean
that patients have, before treatment, encountered
scepticism from outsiders, with even the concern of
those initially sympathetic wearing thin over time.
‘Feeling believed’ refers to the patient’s sense that,
through the establishment of a warm and empathetic
therapeutic alliance, the therapist really understands
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them as an individual with their particular symptoms
and life circumstances. Our analysis would suggest
that it is only at the point at which this is achieved
that the patient can begin to examine their own
symptoms and condition with a view to ‘accepting
the diagnosis’. Although ‘feeling believed’ is likely to
involve the patient presenting their story to the
therapist and necessitate an appropriate empa-
thetic response from the therapist, accepting the
diagnostic label involves a more collaborative
approach between the therapist and patient, with
the patient accepting the symptoms they are
experiencing as real, valid, and a result of having
CFS/ME. Faced with ongoing disbelief as to the
reality of their illness condition, CFS/ME patients
may themselves begin to question the authenticity
of their condition, with implications for patients’
self-identity (Dickson et al., 2007). Patients who
engaged with the intervention described here
commented on the novel experience of being fully
understood as a very positive and important ele-
ment of their experience of treatment and high-
lighted the importance of accepting the condition
before progress in treatment was possible. A vital
role for the GP is to negotiate and prepare a
patient for referral, thus with CFS/ME the GP
must believe that the diagnostic label is helpful
and that any referral for treatment is potentially
valuable. Our previous work (Chew-Graham
et al., 2008) suggests that this is not the case.
A further factor influencing the extent to which
interventions are perceived as acceptable by patients
is the degree to which the models of the illness held
by patient and clinician match. The association
between beliefs about illness and illness outcomes is
well established (Hagger and Orbell, 2003) and
interventions need to take into account existing
beliefs, patient’s past experience and prior ways of
managing illness. If the GP does not have a model of
illness for CFS/ME, has difficulty or reluctance in
making the diagnosis of CFS/ME (Chew-Graham
et al., 2010) then successful initial management in
primary care and appropriate referral will be unlikely.
Clinical implications
This study has important implications, not just for
the management of people with CFS/ME, but also
for the patients with other medically unexplained
symptoms (MUS), or psychological symptoms that
are not easily categorised by current diagnostic
systems. Given that the Improving Access to Psy-
chological Therapies (IAPT) initiative (Department
of Health, 2008) is being proposed as a model for
dealing with patients with MUS, these findings are
relevant to the referral pathways and treatment
models offered.
GPs need to be able to communicate convincingly
to patients that their experience is believed and to
work with patients to come to an agreed diagnosis
before referral is initiated. In addition, GPs need the
skills to explore the patient’s illness cognitions to
ensure they align with the therapy, otherwise any
referral is unlikely to be helpful. For services, the
implication is that before any therapy offered, it is
important to first elicit a patient’s perceptions and
understand the model they hold of their illness.
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